In 2018, the SRF launched CONQUER (COllaborative, National Quality and Efficacy Registry), a first-of-its-kind nationwide, longitudinal registry of scleroderma patients. For those who live with scleroderma, participating in CONQUER is an incredibly meaningful way to advance research and help end this disease. You can make a difference through routine clinical visits at a center in the CONQUER consortium on a semi-annual basis, where your clinician will collect a blood sample and clinical data.
So where are participating centers in the U.S.? Currently, they are in California, Illinois, Maryland, Massachusetts, Michigan, Minnesota, New York, Pennsylvania, South Carolina, Texas, Tennessee, Utah, and Washington, D.C. This includes the three new centers that have joined the CONQUER consortium starting this year—the Mayo Clinic in Minnesota, University of California, Los Angeles, and Vanderbilt University Medical Center.
If you’re interested in participating, visit our page to review your eligibility and find contact information for each center.
Other questions? Reach out! Email Gloria Blecha, Director of Community Engagement, at gloria@sclerodermaresearch.org today.
